RXST Stock Analysis: Buy, Sell, or Hold?

RXST - RxSight, Inc. Common Stock

OPHTHALMIC GOODS
$6.01
-0.07 (-1.15%) ▼
5d: +15.8%
30d: +16.25%
90d: -14.99%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026 1d

Get Alerted When RXST Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD - EXTENDED: RXST is 7.5% above its trading range ($5.59). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: RXST is currently trading at $6.01, which is considered extended relative to its 30-day fair value range of $5.03 to $5.59.

Technical Outlook: Technically, RXST is in a strong downtrend. Immediate support is located at $5.05, while resistance sits at $6.22.

Market Sentiment: RXST has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.06 (+34.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $5.03 - $5.59
Company Quality Score 49/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.9%

All Signals

  • BEARISH: Price extended above range (+7.5% above its trading range)
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 34.2% below Wall St target ($8.06)

Trading Range Analysis

30-Day Trading Range $5.03 - $5.59
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $5.06
Resistance Level $6.23
Current Trend Strong Downtrend
Technical data as of Jul 31, 2026

Fundamental Context

Forward P/E (Next Year Est.) -8.94
Wall Street Target $8.06 (+34.2%)
Revenue Growth (YoY) -18.5%
Profit Margin -36.6%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 02, 2026 11:50 PM ET
Data refreshes hourly during market hours. Next update: 12:50 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for RXST.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BSX
Boston Scientific Corp
STRONG BUY
34 analysts
$64 55 HOLD
DXCM
DexCom Inc
STRONG BUY
27 analysts
$93 49 HOLD
MDT
Medtronic PLC
BUY
32 analysts
$98 57 HOLD
PODD
Insulet Corporation
STRONG BUY
24 analysts
$236 51 HOLD
EW
Edwards Lifesciences Corp
HOLD
32 analysts
$101 52 HOLD

More Analysis for RXST

RXST Technical Chart RXST Price Prediction RXST Earnings Date RXST Investment Advisor RXST Fair Price Analyzer RXST Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals